Abiopharma

NASDAQ symbol attribute type Test_mode was changed. Previous value: N. New value: Meihua International Medical Technologies Co., Ltd. - Class A Ordinary Shares.

NASDAQ symbol attribute type Security_Name was changed. Previous value: EyePoint Pharmaceuticals, Inc. - Common Stock. New value: EyePoint, Inc. - Common Stock.

Becoming a substantial holder

Final approval of ANDA #ANDA #219096 for ACETAMINOPHEN. Decision date: 12/05/2025

RABINOWITZ DANIEL 🟡 adjusted position in 0 shares (1 derivative) of Natera, Inc. (NTRA) at $19.68 Transaction Date: Dec 04, 2025 | Filing ID: 000010

Fischer Laurent 🟢 acquired 128.7K shares of Adverum Biotechnologies, Inc. (ADVM) at $4.31 Transaction Date: Dec 05, 2025 | Filing ID: 000004

Soparkar Peter 🟢 acquired 50.0K shares of Adverum Biotechnologies, Inc. (ADVM) at $4.22 Transaction Date: Dec 05, 2025 | Filing ID: 000004

Director Lo Steven 🟡 adjusted position in 97.2K shares of Vaxart, Inc. (VXRT) at $0.37 Transaction Date: Dec 04, 2025 | Filing ID: 037206

Q & M Dental Group (Singapore) Limited - Announcement

Freeman Chris 🔴 sold 31.5K shares of Guardant Health, Inc. (GH) at $106.71 ($3.2M) Transaction Date: Dec 05, 2025 | Filing ID: 000008

Bell Michael Brian 🟡 adjusted position in 80.4K shares (2 derivative) of Guardant Health, Inc. (GH) at $107.26 ($11.7M) Transaction Date: Dec 05, 2025 | Filing ID: 000008

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Director CLARK IAN T 🟡 adjusted position in 28.6K shares (3 derivative) of Guardant Health, Inc. (GH) at $108.05 ($5.1M) Transaction Date: Dec 05, 2025 | Filing ID: 000007